Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
ARS Pharmaceuticals Inc is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The company is developing neffy, an intranasal epinephrine product in clinical development for pa... ARS Pharmaceuticals Inc is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The company is developing neffy, an intranasal epinephrine product in clinical development for patients and their caregivers with Type I allergic reactions including food, medications, and insect bites that could lead to life-threatening anaphylaxis. Show more
Commercial launch of neffy® (epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by FDA; PDUFA target date set for March 6...
Agreement leverages ALK’s global footprint in developing and commercializing innovative allergy products ARS Pharma to receive an upfront cash payment of $145 million, with total deal...
SAN DIEGO, Nov. 06, 2024 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect...
SAN DIEGO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.19 | -8.05960040637 | 14.765 | 15.25 | 13.01 | 1317724 | 13.88580152 | CS |
| 4 | -2.545 | -15.7878411911 | 16.12 | 18.49 | 13.01 | 1290991 | 15.20687135 | CS |
| 12 | -0.125 | -0.912408759124 | 13.7 | 18.49 | 11 | 1066985 | 14.53099064 | CS |
| 26 | 4.445 | 48.6856516977 | 9.13 | 18.49 | 7.55 | 982003 | 12.82794466 | CS |
| 52 | 8.815 | 185.18907563 | 4.76 | 18.49 | 4.64 | 764275 | 11.12957968 | CS |
| 156 | 8.295 | 157.102272727 | 5.28 | 18.49 | 2.55 | 712047 | 8.48968297 | CS |
| 260 | 8.295 | 157.102272727 | 5.28 | 18.49 | 2.55 | 712047 | 8.48968297 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
